Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
9.13
+0.11 (1.16%)
At close: Jun 5, 2025, 4:00 PM
9.12
-0.01 (-0.05%)
After-hours: Jun 5, 2025, 4:00 PM EDT

Immunome Market Cap

Immunome has a market cap or net worth of $793.99 million as of June 5, 2025. Its market cap has decreased by -4.27% in one year.

Market Cap
793.99M
Enterprise Value
486.22M
1-Year Change
-4.27%
Ranking
Category
Stock Price
$9.13

Market Cap Chart

Since the IPO on October 2, 2020, Immunome's market cap has increased from $111.39M to $793.99M, an increase of 612.79%. That is a compound annual growth rate of 52.23%.

History

DateMarket Cap% Change
Jun 4, 2025784.85M18.40%
Dec 31, 2024662.87M44.98%
Dec 29, 2023457.21M1,605.70%
Dec 30, 202226.80M-82.91%
Dec 31, 2021156.82M53.68%
Dec 31, 2020102.04M-8.39%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 670.72B
Johnson & Johnson 373.90B
AbbVie 330.30B
Novo Nordisk 323.14B
UnitedHealth Group 276.42B
Abbott Laboratories 232.39B
Novartis AG 228.01B
AstraZeneca 222.18B
Market Cap Rankings